Lisinopril Tablet
Product Images NDC 43063-786

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 43063-786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063786 Label (43063786)

Label for LISINOPRIL USP 20 MG 90 TABLETS by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. The label includes the NDC 43063-786-90, lot number C22E23, and expiration date 06/2023. It features dosage forms as tablets, a green warning bar about keeping out of reach of children, and directions to call a doctor for medical advice.*

FDA Label Image

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)

Chemical structure diagram of Lisinopril with two water molecules indicating its dihydrate form. The diagram shows the molecular arrangement relevant to the active ingredient in the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.